Impact of previous biologic use on the efficacy and safety of brodalumab and ustekinumab in patients with moderate-to-severe plaque psoriasis: integrated analysis of the randomized controlled trials AMAGINE-2 and AMAGINE-3

K. A. Papp; K. B. Gordon; R. G. Langley; M. G. Lebwohl; A. B. Gottlieb; S. Rastogi; R. Pillai; R. J. Israel

doi:10.1111/bjd.16464

Impact of previous biologic use on the efficacy and safety of brodalumab and ustekinumab in patients with moderate-to-severe plaque psoriasis: integrated analysis of the randomized controlled trials AMAGINE-2 and AMAGINE-3

K. A. Papp, K. B. Gordon, R. G. Langley, M. G. Lebwohl, A. B. Gottlieb, S. Rastogi, R. Pillai, R. J. Israel

Inernational Relations Division

科研成果: 期刊稿件 › 文章 › 同行评审

59 引用（Scopus）

源语言	英语
页（从-至）	320-328
页数	9
期刊	British Journal of Dermatology
卷	179
期	2
DOI	https://doi.org/10.1111/bjd.16464
出版状态	已出版 - 8月 2018

!!!ASJC Scopus Subject Areas

皮肤医学

访问文件

10.1111/bjd.16464

其它文件与链接

指纹

探究 'Impact of previous biologic use on the efficacy and safety of brodalumab and ustekinumab in patients with moderate-to-severe plaque psoriasis: integrated analysis of the randomized controlled trials AMAGINE-2 and AMAGINE-3' 的科研主题。它们共同构成独一无二的指纹。

引用此

Papp, K. A., Gordon, K. B., Langley, R. G., Lebwohl, M. G., Gottlieb, A. B., Rastogi, S., Pillai, R., & Israel, R. J. (2018). Impact of previous biologic use on the efficacy and safety of brodalumab and ustekinumab in patients with moderate-to-severe plaque psoriasis: integrated analysis of the randomized controlled trials AMAGINE-2 and AMAGINE-3. British Journal of Dermatology, 179(2), 320-328. https://doi.org/10.1111/bjd.16464

Impact of previous biologic use on the efficacy and safety of brodalumab and ustekinumab in patients with moderate-to-severe plaque psoriasis: integrated analysis of the randomized controlled trials AMAGINE-2 and AMAGINE-3. / Papp, K. A.; Gordon, K. B.; Langley, R. G. 等.
在: British Journal of Dermatology, 卷 179, 号码 2, 08.2018, 页码 320-328.

科研成果: 期刊稿件 › 文章 › 同行评审

Papp, KA, Gordon, KB, Langley, RG, Lebwohl, MG, Gottlieb, AB, Rastogi, S, Pillai, R & Israel, RJ 2018, 'Impact of previous biologic use on the efficacy and safety of brodalumab and ustekinumab in patients with moderate-to-severe plaque psoriasis: integrated analysis of the randomized controlled trials AMAGINE-2 and AMAGINE-3', British Journal of Dermatology, 卷 179, 号码 2, 页码 320-328. https://doi.org/10.1111/bjd.16464

Papp KA, Gordon KB, Langley RG, Lebwohl MG, Gottlieb AB, Rastogi S 等. Impact of previous biologic use on the efficacy and safety of brodalumab and ustekinumab in patients with moderate-to-severe plaque psoriasis: integrated analysis of the randomized controlled trials AMAGINE-2 and AMAGINE-3. British Journal of Dermatology. 2018 8月;179(2):320-328. doi: 10.1111/bjd.16464

@article{498388d9ab29483dae00c9816233f140,

title = "Impact of previous biologic use on the efficacy and safety of brodalumab and ustekinumab in patients with moderate-to-severe plaque psoriasis: integrated analysis of the randomized controlled trials AMAGINE-2 and AMAGINE-3",

author = "Papp, {K. A.} and Gordon, {K. B.} and Langley, {R. G.} and Lebwohl, {M. G.} and Gottlieb, {A. B.} and S. Rastogi and R. Pillai and Israel, {R. J.}",

note = "Publisher Copyright: {\textcopyright} 2018 British Association of Dermatologists",

year = "2018",

month = aug,

doi = "10.1111/bjd.16464",

language = "English",

volume = "179",

pages = "320--328",

journal = "British Journal of Dermatology",

issn = "0007-0963",

publisher = "Wiley-Blackwell",

number = "2",

}

TY - JOUR

T1 - Impact of previous biologic use on the efficacy and safety of brodalumab and ustekinumab in patients with moderate-to-severe plaque psoriasis

T2 - integrated analysis of the randomized controlled trials AMAGINE-2 and AMAGINE-3

AU - Papp, K. A.

AU - Gordon, K. B.

AU - Langley, R. G.

AU - Lebwohl, M. G.

AU - Gottlieb, A. B.

AU - Rastogi, S.

AU - Pillai, R.

AU - Israel, R. J.

PY - 2018/8

Y1 - 2018/8

UR - http://www.scopus.com/inward/record.url?scp=85052198325&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85052198325&partnerID=8YFLogxK

U2 - 10.1111/bjd.16464

DO - 10.1111/bjd.16464

M3 - Article

C2 - 29488226

AN - SCOPUS:85052198325

SN - 0007-0963

VL - 179

SP - 320

EP - 328

JO - British Journal of Dermatology

JF - British Journal of Dermatology

IS - 2

ER -